| Patient | Eva Perón |
|---|---|
| Date of birth | 1919-05-07 |
| Identifiers | MRN HR-ML025-SYN-TD; SSN (made up) 000-25-7316 |
| Document date | 1951-02-17 |
| Author | Lucía Barragán, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Biopsy result, and gynecologic oncology consultation the same day. [S]
Ms. Perón returns eight days after her first visit, as arranged, to hear her biopsy result in person; the visit is in Spanish. Before giving the result, Dr. Barragán asked what she understood so far and how she wanted to hear news. She said she suspected something serious, wanted to know everything, directly and herself, and wanted no one else in the room. She was told plainly that the biopsy shows a cancer of the cervix, an invasive squamous cell carcinoma, and that the HPV test found HPV type 16 and the cytology also showed cancer cells. After a pause and some tears she asked whether it can be cured, whether she will be able to work, and whether she could have children. Dr. Osei-Bonsu of gynecologic oncology then joined, with a professional Spanish interpreter, as Ms. Perón agreed. Since the first visit the bleeding has been lighter, she takes the iron daily with dark stools and no stomach upset, and she uses acetaminophen once or twice a day for the pelvic ache. [S]
| Element | Detail |
|---|---|
| Result given | Invasive squamous cell carcinoma of the cervix; HPV 16 positive; cytology with cancer cells |
| How it was given | In person, in Spanish, to her alone, after asking what she wanted to know |
| Her questions | Cure, work, and children |
| Bleeding | Lighter; iron taken daily |
| Scores | Pelvic pain 4 of 10; PHQ-9 9; GAD-7 9 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever or weight loss |
| Genitourinary | Positive | Lighter bleeding; no urinary symptoms or blood in the urine |
| Gastrointestinal | Negative | Dark stools on iron; no rectal bleeding or pain on opening the bowels |
| Musculoskeletal | Negative | No back or leg pain; no leg swelling |
| Psychiatric | Positive | Shocked and frightened by the news; no thoughts of self-harm |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairy | One tablet by mouth once daily | Oral route | 1951-02-09 to 1951-08-17 | completed | S |
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a day | One or two tablets every 6 hours when needed, no more than 6 a day | Oral route | 1951-02-09 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1951-02-17 | Body height | 165 | cm | S |
| 1951-02-17 | Body weight | 52.8 | kg | S |
| 1951-02-17 | Body mass index (BMI) [Ratio] | 19.4 | kg/m2 | S |
| 1951-02-17 | Systolic blood pressure | 112 | mm[Hg] | S |
| 1951-02-17 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1951-02-17 | Heart rate | 90 | /min | S |
| 1951-02-17 | Respiratory rate | 16 | /min | S |
| 1951-02-17 | Body temperature | 36.7 | Cel | S |
| 1951-02-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1951-02-17 | Creatinine [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 1951-02-17 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1946)/1.73 sq M | 117 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1951-02-17 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S | ||
| 1951-02-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S | ||
| 1951-02-17 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S |
Vital signs recorded on 1951-02-17; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Pale; pulse 90, blood pressure 112/70 |
| Abdomen | Soft; no mass; no enlarged liver |
| Lymph nodes | No inguinal or supraclavicular nodes |
| Pelvic | Examined by Dr. Osei-Bonsu with Ms. Perón's consent and a chaperone: a friable exophytic tumor about 4.5 cm across replacing the cervix; colposcopy of the vagina shows no spread to the vaginal walls; on rectovaginal examination the left parametrium is thickened and nodular but does not reach the pelvic wall; the right parametrium and the rectal mucosa are free |
| Psychiatric | Tearful at first, then composed; asking clear questions; no thoughts of self-harm |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation booked | resolved | confirmed | N93.8 | S — Synthetic presenting problem linked to her documented abnormal bleeding with anemia; superseded by the diagnosis at the consultation. |
| Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairs | active | confirmed | D50.0 | S — Synthetic modern finding linked to her documented anemia from vaginal bleeding. |
| Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 1943 staging. Synthetic modern episode linked to her documented cervical cancer | active | confirmed | C53.9 | S — Synthetic modern diagnosis made at the gynecologic oncology consultation. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Self-management | Disclosure and information preferences: she is told first, in Spanish, as much as she wants to know; she decides who else is told | Every visit | Completed today | Told in person, in Spanish, alone as she asked, after checking what she wanted to know; she asked about cure, work and children, and each question was answered |
| Examination | Pelvic, speculum and rectovaginal examination | At diagnosis; every three to six months for two years after treatment | Completed today | About 4.5 cm tumor; left parametrial spread not reaching the pelvic wall; vagina and rectum free |
| Imaging | Pelvic MRI | At staging, for local extent | Ordered | Within ten days |
| Imaging | FDG PET-CT | At staging; about three months after chemoradiation | Ordered | Within ten days, for nodes and distant spread |
| Laboratory | Kidney function (creatinine, eGFR) and magnesium for cisplatin | Before cisplatin, weekly during it, and after | Completed today | Creatinine 0.7 mg/dL, eGFR 117 |
| Laboratory | HIV and hepatitis C tests | At diagnosis | Ordered | Drawn today with her agreement |
| Laboratory | Blood count (hemoglobin, white cells, platelets) | About one month after starting oral iron, then every three months for a year; weekly during chemoradiation | Due | Hemoglobin 9.4 g/dL eight days ago; next at about one month |
| Survey | Pelvic pain score and analgesic safety (no anti-inflammatory painkillers with cisplatin) | Every visit | Completed today | 4 of 10; acetaminophen once or twice a day |
| Survey | PHQ-9 and GAD-7 | At diagnosis, before treatment, at mid-treatment, at the end of treatment, and in follow-up | Completed today | PHQ-9 9 (item 9 scored 0), GAD-7 9, on the day of diagnosis |
| Referral | Fertility and ovarian function counseling and her decision | Before cancer treatment begins | Completed today | Options explained; her decision due at the next visit |
| Referral | Oncology social worker and spiritual care | At diagnosis and through treatment | Completed today | Social worker met her today; spiritual care offered |
Goal progress:
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Revised FIGO staging for carcinoma of the cervix uteri (2018 (published 2019)); Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017); Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update (2018); Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026)
Follow-up: Results of MRI, PET-CT, HIV and hepatitis C tests at a visit in about two weeks, with Dr. Osei-Bonsu, when the stage, treatment, and her fertility decision will be discussed. Next scheduled visit 1951-03-02: staging results (pelvic MRI and PET-CT), FIGO stage, and her treatment and fertility decisions before chemoradiation. [S]